Deferred prosecution agreements in two cases against companies that peddled opioids highlight the need for both personal and corporate accountability.
prescription drugs
Three Bernie Sanders Bills to Arrest the Highway Robbery in the Prescription Drug Market
Allowing foreign imports, authorizing Medicare bargaining, or setting prices at what other nations pay—all good options
Trump Eliminates the Middleman
His administration takes aim at the heretofore legal kickbacks to prescription drug distributors—but leaves the drug companies themselves untouched.
The Corporate Scam that Even Trump Opposes: PBMs
The administration’s welcome proposal to break up pharmacy benefit managers
The Hidden Monopolies That Raise Drug Prices
How pharmacy benefit managers morphed from processors to predators
Big Pharma’s Private War on Drugs
Pharmacy robberies have spiked in large part thanks to illegal demand for OxyContin. A look inside the drugmaker’s efforts to protect its product and the pharmacists at the front lines.
